Equity Capital And Reserves Changement Date
Acadia Pharmaceuticals USD 431.76M 69.58M 2023-12
Agios Pharmaceuticals USD 811.02M 75.82M 2023-12
Alnylam Pharmaceuticals USD -220644000 54.78M 2023-12
Amarin USD 553.15M 15.98M 2023-09
Amgen USD 6.23B 1.42B 2023-12
Baxter International USD 8.4B 301M 2023-12
Cara Therapeutics USD 85.64M 23.29M 2023-09
Cytokinetics USD -386323000 52.48M 2023-12
Eli Lilly USD 11.22B 156.6M 2023-09
Esperion Therapeutics USD -410004000 38.03M 2023-09
Halozyme Therapeutics USD 83.81M 165.37M 2023-12
Intra Cellular Therapies USD 591.42M 9.26M 2023-12
Intrexon USD 147.68M 18.53M 2023-09
Ionis Pharmaceuticals USD 386.69M 71.23M 2023-12
MannKind USD -246168000 5.61M 2023-12
Minerva Neurosciences USD -20046000 7.53M 2023-09
Nektar Therapeutics USD 159.37M 37.59M 2023-09
Peregrine Pharmaceuticals USD 183.68M 6.92M 2023-09
Pfizer USD 96.93B 2.08B 2023-09
Rigel Pharmaceuticals USD -31834000 3.72M 2023-09
United Therapeutics USD 5.98B 272.7M 2023-12
Vanda Pharmaceuticals USD 539.9M 4.16M 2023-06



Halozyme Therapeutics Capitaux Propres Et Réserves - Les valeurs actuelles, des données historiques, des prévisions, des statistiques, des tableaux et le calendrier économique - Mar 2024.